Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Merck Bids To Stay Ahead In IO With IOmet Buy

This article was originally published in Scrip

Executive Summary

Merck & Co. Inc is buying IOmet Pharma in hopes the small Scottish start-up – which focuses on IDO/TDO inhibitors – will help it maintain a top position in the exploding field of immuno-oncology.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register